Influence of cholesterol crystallization effector proteins on vesicle fusion in supersaturated model bile

Journal of Gastroenterology and Hepatology (Australia)

Volumn 14, Issue 7, 1999, Pages 669-674

  Hattori, Yoshihiro ^a   Tazuma, Susumu ^a   Yamashita, Gunji ^a   Kajiyama, Goro ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Biliary protein; Fusion; Liposome; Protein hydrophobicity

Indexed keywords

ALBUMIN; APOLIPOPROTEIN A; APOLIPOPROTEIN B; CHOLESTEROL; CONCANAVALIN A; GLYCOPROTEIN; IMMUNOGLOBULIN; LIPOSOME; PHOSPHOLIPID; RHODAMINE B;

ARTICLE; BILE; COLUMN CHROMATOGRAPHY; CRYSTALLIZATION; FLUORESCENCE; GALLSTONE FORMATION; HYDROPHOBICITY; MICELLE; PHASE CONTRAST MICROSCOPY; PHOSPHOLIPID VESICLE; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; QUANTITATIVE ASSAY;

EID: 0032777666     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.1999.01933.x     Document Type: Article

References (25)

1. 1 Holzbach RT. Current concepts of cholesterol transport and crystal formation in human bile. Hepatology 1990; 12: 26-32.
2. 2 Holan KR, Holzbach RT, Hermann RE, Cooperman AM, Claffey WJ. Nucleation time: A key factor in the pathogenesis of cholesterol gallstone disease. Gastroenterology 1979; 77: 611-17.
3. 3 Yamashita G, Secknus R, Chernosky A, Krivacic KA, Holzbach RT. Comparison of haptoglobin and apolipoprotein A-1 on biliary lipid particles involved in cholesterol crystallization. J. Gastroenterol. Hepatol. 1996; 11: 738-45.
4. 4 Teramen K, Tazuma S, Ohya T, Kajiyama G. Comparative effects on biliary concanavalin A-bound glycoproteins and calcium ion on cholesterol crystal nucleation and growth in model bile. J. Gastroenterol. 1995; 30: 500-7.
5. 5 Yamashita G, Corradini SG, Secknus R et al. Biliary haptoglobin, a potency promoter of cholesterol crystallization at physiological concentrations. J. Lipid Res. 1995; 36: 1325-33.
6. 6 Offner GD, Dahai G, Afdhal NH. Identification of a 130-kilodalton human biliary concanavalin A binding protein as aminopeptidase N. Gastroenterology 1994; 106: 755-62.
7. 7 Ohya T, Schwarzendrube J, Busch N et al. Isolation of human biliary glycoprotein inhibitor of cholesterol crystallization. Gastroenterology 1993; 104: 527-38.
8. 8 Kibe A, Holzbach RT, LaRusso NF, Mao SJT. Inhibition of cholesterol crystal formation by apolipoproteins in supersaturated model bile. Science 1984; 225: 514-16.
9. 9 Harvey PRC, Upadhya GA, Strasberg SM. Immunoglobulins as nucleating proteins in the gallbladder bile of patients with cholesterol gallstones. J. Biol. Chem. 1991; 266: 13 996-4003.
10. 10 Groen AK. Nonmucous glycoproteins as pronucleating agents. Hepatology 1990; 12: 189-94.
11. 11 Abei M, Nuutinen H, Langnas A, Svanvik J, Holzbach RT. Isolation and characterization of a cholesterol crystallization-promotor from human bile. Gastroenterology 1993; 104: 539-48.
12. 1-acid glycoprotein as a cholesterol crystallization promotor. Gastoenterology 1994; 106: 231-8.
13. 1-acid glycoprotein, phospholipase C and aminopeptidase N. J. Lipid Res. 1993; 34: 1141-8.
14. 14 Halpern Z, Lafont H, Arad J et al. The distribution of the biliary-anionic polypeptide fraction between cholesterol carriers in bile and its effect on nucleation. J. Hepatol. 1994; 21: 979-83.
15. 15 Tao S, Tazuma S, Kajiyama G. Apolipoprotein A-I stabilizes phospholipid lamellae and thus prolongs nucleation time in model bile systems: An ultrastructural study. Biochim. Biophys. Acta 1993; 1166: 25-35.
16. 16 Ahmed HA, Petroni ML, Abu-Hamdiyyah M et al. Hydrophobic/hydrophilic balance of proteins: A major determinant of cholesterol crystal formation in model bile. J. Lipid Res. 1994; 35: 211-19.
17. 17 Hattori Y, Tazuma S, Yamashita G, Kajiyama G. Comparative potency of cholesterol crystallization-effector proteins in supersaturated model bile systems: Association with vesicle transformation. J. Gastroenterol. Hepatol. 1999; (in press).
18. 18 Yamashita Y, Tazuma S, Kajiyama G. Method for quantitative assessment of transformation of non-micellar cholesterol carriers in model bile systems. J. Gastroenterol. Hepatol. 1996; 11: 864-9.
19. 19 Hirano N, Tazuma S, Kajiyama G. Transcytotic vesicle fusion with canalicular membranes is modulated by phospholipid species: Implications for biliary lipid secretion. J. Gastroenterol. Hepatol. 1997; 12: 534-9.
20. 2+ and NaK-ATPase activity. J. Lab. Clin. Med. 1979; 93: 790-9.
21. 21 Mayuhaus D, Lichtenberg D. The effect of albumin on the state of aggregation and phase transformations in phosphatidylcholine-sodium cholate mixtures. Biochim. Biophys. Acta 1995; 1234: 203-13.
22. 22 Francis JW, Smolen JE, Balazovich KJ, Sandborg RR, Boxer LA. Calcium-dependent fusion of the plasma membrane fraction from human neutrophils with liposomes. Biochim. Biophys. Acta 1990; 1025: 1-9.
23. 23 Halpern Z, Dudley MA, Kibe A, Lynn MP, Breurer AC, Holzbach RT. Rapid vesicle formation and aggregation in abnormal human biles: A time-lapse video-enhanced contrast microscopy study. Gastroenterology 1986; 90: 875-85.
24. 24 Halpern Z, Dudley MA, Lynn MP et al. Vesicle aggregation in model systems of supersaturated bile: Relation to crystal nucleation and lipid composition of the vesicular phase. J. Lipid Res. 1986; 27: 295-306.
25. 25 Afdhal NH, Niu N, Nunes DP et al. Mucin-vesicle interaction in model bile: Evidence for vesicle aggregation and fusion before cholesterol crystal formation. Hepatology 1995; 22: 856-65.